Company’s affordable, benefit-rich flagship PPO plans now have 4 Star ratingFRANKLIN, Tenn., Oct. 15, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CLOV) (“Clover” or “the Company”) has announced the debut of ...

15, 2024 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV ... low specialist and prescription drug copays, enhanced OTC and dental allowances, and a rewards program with the potential to ...

15, 2024 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV) ("Clover” or "the Company”) has announced the debut ... while delivering added value to members including low specialist and prescription drug ...

Analyst Richard Close from Canaccord Genuity maintained a Buy rating on Clover Health Investments (CLOV – Research Report) and keeping the price target at $3.20. Richard Close has given his Buy ...

Clover Health Investments shares are trading higher by 4.6% Friday afternoon. The company announced that CMS raised its PPO Medicare Advantage plans' Star rating to 4 Stars for 2025. What To Know ...

Clover Health Investments shares are trading higher by 4.6% Friday afternoon. The company announced that CMS raised its PPO Medicare Advantage plans' Star rating to 4 Stars for 2025. Henry ...

Clover Health specializes in aiding Medicare physicians with early chronic disease management through its proprietary cloud-based software, Clover Assistant. After years of unprofitability ...

FRANKLIN, Tenn., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today ...